Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism
Catherine Duane, John P. Quinn, Siobhán Glavey, Philip Murphy
Journal
Haematologica
Topics
Multiple Myeloma Research and Treatments
article
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism
Catherine Duane, John P. Quinn, Siobhán Glavey, Philip Murphy
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(10)
Institutions
University of Medicine and Health Sciences (KN), Beaumont Hospital (IE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism — Catherine Duane, John P. Quinn, et al. · Haematologica (2025) | TGRS Research Map | TGRS